Charles River Laboratories International (CRL) Operating Expenses (2009 - 2025)

Charles River Laboratories International's Operating Expenses history runs 17 years deep, the most recent figure standing at $196.1 million for Q4 2025.

• In Q4 2025, Operating Expenses changed 0.22% year-over-year to $196.1 million; the TTM figure through Dec 2025 stood at $743.1 million (down 1.06% YoY), while the FY2025 annual figure was $743.1 million, down 1.06% from the prior year.
• Operating Expenses for Q4 2025 stood at $196.1 million, up from $177.6 million in the prior quarter.
• The five-year high for Operating Expenses was $199.8 million in Q3 2023, with the low at $131.7 million in Q2 2022.
• The 5-year median for Operating Expenses is $177.7 million (2025), against an average of $176.3 million.
• The sharpest annual moves came in 2022 and 2023: Operating Expenses fell 23.2% in 2022, then soared 51.66% in 2023.
• Charles River Laboratories International's Operating Expenses stood at $144.1 million in 2021, then jumped by 38.53% to $199.6 million in 2022, then dropped by 1.25% to $197.1 million in 2023, then decreased by 0.73% to $195.7 million in 2024, then climbed by 0.22% to $196.1 million in 2025.
• Business Quant data shows CRL's Operating Expenses at $196.1 million in Q4 2025, $177.6 million in Q3 2025, and $191.5 million in Q2 2025.